| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Activins | 41 | 2016 | 54 | 5.060 |
Why?
|
| Inhibins | 41 | 2018 | 50 | 4.640 |
Why?
|
| Follistatin | 39 | 2012 | 44 | 3.570 |
Why?
|
| Follistatin-Related Proteins | 18 | 2016 | 22 | 3.050 |
Why?
|
| Transforming Growth Factor beta | 16 | 2020 | 172 | 2.560 |
Why?
|
| Glycoproteins | 24 | 2002 | 187 | 2.150 |
Why?
|
| Insulin-Secreting Cells | 4 | 2016 | 190 | 1.560 |
Why?
|
| Bone Morphogenetic Proteins | 8 | 2020 | 62 | 1.500 |
Why?
|
| Ovarian Follicle | 13 | 2016 | 40 | 1.430 |
Why?
|
| Islets of Langerhans | 6 | 2016 | 279 | 1.350 |
Why?
|
| Glucagon-Secreting Cells | 4 | 2016 | 26 | 1.180 |
Why?
|
| Ovary | 8 | 2014 | 99 | 1.090 |
Why?
|
| Follicular Fluid | 11 | 2005 | 15 | 1.010 |
Why?
|
| Inhibin-beta Subunits | 5 | 2012 | 7 | 1.000 |
Why?
|
| Polycystic Ovary Syndrome | 7 | 2005 | 23 | 0.990 |
Why?
|
| Insulin Resistance | 3 | 2013 | 410 | 0.910 |
Why?
|
| Follicle Stimulating Hormone | 19 | 2018 | 84 | 0.870 |
Why?
|
| Insulin | 5 | 2015 | 687 | 0.810 |
Why?
|
| Glucose | 3 | 2011 | 469 | 0.780 |
Why?
|
| Granulosa Cells | 8 | 2007 | 16 | 0.740 |
Why?
|
| Homeostasis | 5 | 2012 | 367 | 0.710 |
Why?
|
| Growth Substances | 5 | 2001 | 34 | 0.690 |
Why?
|
| Animals | 57 | 2020 | 20582 | 0.690 |
Why?
|
| Testis | 9 | 2016 | 141 | 0.640 |
Why?
|
| Myostatin | 5 | 2012 | 14 | 0.630 |
Why?
|
| RNA, Messenger | 15 | 2011 | 1528 | 0.620 |
Why?
|
| Cell Transdifferentiation | 2 | 2016 | 15 | 0.620 |
Why?
|
| Nerve Tissue Proteins | 7 | 2016 | 422 | 0.620 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2015 | 639 | 0.590 |
Why?
|
| Receptors, Growth Factor | 8 | 2005 | 19 | 0.590 |
Why?
|
| Ovarian Neoplasms | 6 | 1999 | 144 | 0.570 |
Why?
|
| Mice | 25 | 2018 | 10805 | 0.550 |
Why?
|
| Protein Isoforms | 5 | 2011 | 199 | 0.530 |
Why?
|
| Blood Glucose | 3 | 2016 | 485 | 0.480 |
Why?
|
| Fertility | 4 | 2018 | 80 | 0.470 |
Why?
|
| Activin Receptors | 9 | 2008 | 12 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 690 | 0.460 |
Why?
|
| Mice, Knockout | 9 | 2018 | 2099 | 0.460 |
Why?
|
| Immunohistochemistry | 8 | 2016 | 890 | 0.460 |
Why?
|
| Protein Precursors | 4 | 1996 | 83 | 0.440 |
Why?
|
| Radioimmunoassay | 15 | 2001 | 63 | 0.430 |
Why?
|
| Female | 61 | 2018 | 32495 | 0.430 |
Why?
|
| Fetus | 2 | 2011 | 99 | 0.410 |
Why?
|
| Receptors, FSH | 7 | 1992 | 8 | 0.410 |
Why?
|
| Reproduction | 3 | 2009 | 92 | 0.410 |
Why?
|
| Male | 41 | 2018 | 29487 | 0.390 |
Why?
|
| Humans | 74 | 2020 | 62687 | 0.380 |
Why?
|
| Neural Cell Adhesion Molecules | 3 | 2010 | 13 | 0.380 |
Why?
|
| Cells, Cultured | 10 | 2018 | 2154 | 0.380 |
Why?
|
| Fatty Liver | 1 | 2013 | 108 | 0.380 |
Why?
|
| Prostatic Secretory Proteins | 3 | 2001 | 3 | 0.370 |
Why?
|
| Activin Receptors, Type II | 3 | 2007 | 9 | 0.370 |
Why?
|
| Signal Transduction | 13 | 2020 | 3022 | 0.360 |
Why?
|
| Liver | 3 | 2013 | 845 | 0.350 |
Why?
|
| Phenols | 1 | 2011 | 78 | 0.350 |
Why?
|
| Dietary Fats | 1 | 2011 | 176 | 0.340 |
Why?
|
| Aging | 3 | 2013 | 740 | 0.340 |
Why?
|
| Recombinant Proteins | 15 | 2006 | 700 | 0.330 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1346 | 0.330 |
Why?
|
| Germ Cells | 1 | 2010 | 105 | 0.330 |
Why?
|
| Metabolic Syndrome | 1 | 2011 | 142 | 0.330 |
Why?
|
| Luteinizing Hormone | 8 | 2005 | 99 | 0.320 |
Why?
|
| Oocytes | 3 | 2000 | 196 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 8 | 2018 | 3387 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 544 | 0.310 |
Why?
|
| Cell Line | 11 | 2015 | 2038 | 0.300 |
Why?
|
| Embryonic Development | 1 | 2009 | 134 | 0.300 |
Why?
|
| Adipose Tissue | 1 | 2011 | 296 | 0.300 |
Why?
|
| Immunoassay | 4 | 2004 | 70 | 0.300 |
Why?
|
| Cleft Palate | 1 | 2007 | 42 | 0.270 |
Why?
|
| Menstrual Cycle | 4 | 2003 | 81 | 0.270 |
Why?
|
| Proteins | 7 | 2013 | 750 | 0.260 |
Why?
|
| Protein Binding | 11 | 2018 | 1601 | 0.260 |
Why?
|
| Proteoglycans | 3 | 2018 | 32 | 0.260 |
Why?
|
| Pregnancy | 11 | 2018 | 2318 | 0.250 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 50 | 0.240 |
Why?
|
| Ligands | 8 | 2013 | 417 | 0.240 |
Why?
|
| Molecular Sequence Data | 12 | 2006 | 1992 | 0.230 |
Why?
|
| Estradiol | 8 | 2005 | 257 | 0.220 |
Why?
|
| Rats | 11 | 2015 | 1978 | 0.220 |
Why?
|
| Mutation | 4 | 2011 | 2573 | 0.220 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 1611 | 0.210 |
Why?
|
| Gonadotropins | 4 | 2004 | 14 | 0.210 |
Why?
|
| Flow Cytometry | 3 | 2016 | 669 | 0.210 |
Why?
|
| Paracrine Communication | 2 | 2004 | 15 | 0.210 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2018 | 28 | 0.210 |
Why?
|
| Obesity | 1 | 2011 | 1230 | 0.200 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2003 | 35 | 0.200 |
Why?
|
| Hepatocytes | 2 | 2016 | 215 | 0.200 |
Why?
|
| Mice, 129 Strain | 2 | 2013 | 41 | 0.200 |
Why?
|
| Gene Expression | 4 | 2014 | 837 | 0.200 |
Why?
|
| Body Weight | 4 | 2011 | 377 | 0.200 |
Why?
|
| Molecular Weight | 13 | 2000 | 188 | 0.200 |
Why?
|
| Binding, Competitive | 6 | 2008 | 100 | 0.200 |
Why?
|
| Teratocarcinoma | 2 | 1999 | 4 | 0.190 |
Why?
|
| Adult | 19 | 2015 | 16629 | 0.190 |
Why?
|
| Amino Acid Sequence | 9 | 2006 | 1594 | 0.180 |
Why?
|
| Progesterone | 6 | 2000 | 162 | 0.180 |
Why?
|
| Uterus | 2 | 2014 | 42 | 0.170 |
Why?
|
| Hormones | 1 | 2000 | 60 | 0.170 |
Why?
|
| Carcinoma | 2 | 1998 | 125 | 0.170 |
Why?
|
| Reference Values | 6 | 2003 | 335 | 0.170 |
Why?
|
| Cell Division | 8 | 2003 | 450 | 0.160 |
Why?
|
| Blotting, Western | 9 | 2004 | 610 | 0.160 |
Why?
|
| Organ Size | 3 | 2013 | 171 | 0.160 |
Why?
|
| Radioligand Assay | 5 | 1992 | 24 | 0.160 |
Why?
|
| Fertilization in Vitro | 6 | 2003 | 84 | 0.160 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 7 | 2004 | 182 | 0.160 |
Why?
|
| Kinetics | 6 | 2007 | 764 | 0.160 |
Why?
|
| Body Fluids | 3 | 1996 | 21 | 0.160 |
Why?
|
| Gonadotrophs | 1 | 2018 | 5 | 0.150 |
Why?
|
| Pituitary Gland | 4 | 2002 | 51 | 0.150 |
Why?
|
| Body Composition | 2 | 2011 | 152 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 4 | 2008 | 670 | 0.140 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 1997 | 2 | 0.140 |
Why?
|
| Testicular Neoplasms | 1 | 1998 | 34 | 0.140 |
Why?
|
| Hepcidins | 2 | 2016 | 3 | 0.140 |
Why?
|
| Steroids | 1 | 1997 | 54 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2001 | 623 | 0.140 |
Why?
|
| Immunoblotting | 3 | 2016 | 204 | 0.140 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1271 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 453 | 0.140 |
Why?
|
| Testosterone | 3 | 2005 | 119 | 0.130 |
Why?
|
| Glycopeptides | 3 | 1991 | 12 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 206 | 0.130 |
Why?
|
| CHO Cells | 4 | 2006 | 190 | 0.130 |
Why?
|
| Trans-Activators | 3 | 2015 | 311 | 0.130 |
Why?
|
| Glycosylation | 3 | 2005 | 138 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 6 | 2002 | 456 | 0.130 |
Why?
|
| Pregnancy, Ectopic | 1 | 1996 | 10 | 0.130 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2016 | 5 | 0.130 |
Why?
|
| Cricetinae | 4 | 2006 | 368 | 0.130 |
Why?
|
| COS Cells | 3 | 2006 | 174 | 0.120 |
Why?
|
| Embryo, Mammalian | 4 | 2018 | 157 | 0.120 |
Why?
|
| Primary Ovarian Insufficiency | 2 | 1992 | 8 | 0.120 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 128 | 0.120 |
Why?
|
| Cell Count | 2 | 2013 | 130 | 0.120 |
Why?
|
| Prenatal Diagnosis | 1 | 1996 | 39 | 0.120 |
Why?
|
| MafB Transcription Factor | 1 | 2015 | 5 | 0.120 |
Why?
|
| Paired Box Transcription Factors | 1 | 2015 | 16 | 0.120 |
Why?
|
| Glucagon | 1 | 2015 | 33 | 0.120 |
Why?
|
| Osteocytes | 1 | 2015 | 12 | 0.120 |
Why?
|
| Down Syndrome | 1 | 1996 | 47 | 0.120 |
Why?
|
| Antibody Specificity | 4 | 2004 | 103 | 0.120 |
Why?
|
| Estrous Cycle | 1 | 2014 | 12 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2010 | 981 | 0.110 |
Why?
|
| Blood Proteins | 1 | 1994 | 76 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2015 | 142 | 0.110 |
Why?
|
| Androstenedione | 3 | 2005 | 8 | 0.110 |
Why?
|
| Osteoblasts | 1 | 2015 | 198 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2005 | 533 | 0.110 |
Why?
|
| GPI-Linked Proteins | 5 | 2016 | 41 | 0.110 |
Why?
|
| Macromolecular Substances | 5 | 1996 | 160 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 267 | 0.110 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2013 | 1 | 0.100 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2013 | 2 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 28 | 0.100 |
Why?
|
| Glucose Intolerance | 2 | 2011 | 90 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2015 | 622 | 0.100 |
Why?
|
| Tissue Distribution | 2 | 2005 | 293 | 0.100 |
Why?
|
| Time Factors | 5 | 2015 | 3742 | 0.100 |
Why?
|
| Semen | 1 | 1993 | 44 | 0.100 |
Why?
|
| Infertility, Male | 1 | 1993 | 57 | 0.100 |
Why?
|
| Transfection | 2 | 2008 | 691 | 0.100 |
Why?
|
| Heparin | 2 | 2004 | 116 | 0.100 |
Why?
|
| In Vitro Techniques | 3 | 2001 | 487 | 0.100 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 36 | 0.100 |
Why?
|
| Gestational Age | 2 | 2007 | 188 | 0.100 |
Why?
|
| Biological Availability | 1 | 2013 | 200 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 573 | 0.090 |
Why?
|
| Rats, Inbred Lew | 1 | 2011 | 106 | 0.090 |
Why?
|
| In Situ Hybridization | 2 | 2005 | 217 | 0.090 |
Why?
|
| Body Fluid Compartments | 1 | 2011 | 3 | 0.090 |
Why?
|
| Triglycerides | 1 | 2013 | 244 | 0.090 |
Why?
|
| Cross Reactions | 5 | 1996 | 131 | 0.090 |
Why?
|
| Ovarian Diseases | 1 | 1991 | 19 | 0.090 |
Why?
|
| Ovulation | 2 | 2001 | 28 | 0.090 |
Why?
|
| Fasting | 1 | 2011 | 51 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 669 | 0.090 |
Why?
|
| Species Specificity | 1 | 2011 | 334 | 0.090 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 2010 | 3 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 47 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 62 | 0.090 |
Why?
|
| Type C Phospholipases | 1 | 1990 | 33 | 0.090 |
Why?
|
| Receptors, LH | 1 | 1990 | 2 | 0.090 |
Why?
|
| Mammary Glands, Human | 1 | 2011 | 56 | 0.090 |
Why?
|
| Genotype | 2 | 2011 | 649 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2007 | 889 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2003 | 431 | 0.090 |
Why?
|
| Sarcopenia | 1 | 2010 | 22 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2011 | 79 | 0.090 |
Why?
|
| Pancreas | 1 | 2011 | 149 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 233 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2010 | 236 | 0.080 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 1996 | 87 | 0.080 |
Why?
|
| Chromatography, Gel | 3 | 1996 | 65 | 0.080 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2010 | 35 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2009 | 369 | 0.080 |
Why?
|
| Pregnancy Trimester, First | 1 | 2009 | 26 | 0.080 |
Why?
|
| Cattle | 6 | 1995 | 308 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 5 | 2004 | 866 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 769 | 0.080 |
Why?
|
| Crystallography, X-Ray | 3 | 2008 | 431 | 0.080 |
Why?
|
| Immune Sera | 4 | 1995 | 35 | 0.080 |
Why?
|
| Actins | 2 | 2001 | 259 | 0.080 |
Why?
|
| Middle Aged | 6 | 2014 | 17365 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 862 | 0.080 |
Why?
|
| Luteolysis | 1 | 2009 | 1 | 0.080 |
Why?
|
| Cell Membrane | 3 | 2006 | 493 | 0.080 |
Why?
|
| Sex Determination Processes | 1 | 2009 | 8 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2010 | 148 | 0.080 |
Why?
|
| Follicular Phase | 3 | 1994 | 15 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 156 | 0.080 |
Why?
|
| Inflammation | 1 | 2016 | 1138 | 0.080 |
Why?
|
| Endocrine Disruptors | 1 | 2010 | 77 | 0.080 |
Why?
|
| Swine | 5 | 1995 | 368 | 0.080 |
Why?
|
| Growth Differentiation Factors | 1 | 2008 | 3 | 0.070 |
Why?
|
| Binding Sites | 5 | 2008 | 900 | 0.070 |
Why?
|
| Cell-Free System | 2 | 2004 | 31 | 0.070 |
Why?
|
| Palate | 1 | 2007 | 8 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 35 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 105 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 108 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1452 | 0.070 |
Why?
|
| Diabetes, Gestational | 1 | 2009 | 141 | 0.070 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2007 | 5 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2010 | 389 | 0.070 |
Why?
|
| Activin Receptors, Type I | 2 | 2004 | 14 | 0.070 |
Why?
|
| Aged | 4 | 2015 | 14254 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2015 | 1508 | 0.070 |
Why?
|
| Young Adult | 2 | 2015 | 4633 | 0.070 |
Why?
|
| Stem Cells | 1 | 2009 | 259 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2009 | 1110 | 0.070 |
Why?
|
| Iodine Radioisotopes | 1 | 1986 | 53 | 0.070 |
Why?
|
| Research Design | 1 | 2010 | 572 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 495 | 0.060 |
Why?
|
| Dolphins | 1 | 1985 | 3 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 1638 | 0.060 |
Why?
|
| Smad1 Protein | 3 | 2016 | 5 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2006 | 60 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 68 | 0.060 |
Why?
|
| Luciferases | 2 | 2004 | 109 | 0.060 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2005 | 4 | 0.060 |
Why?
|
| Methionine | 1 | 2005 | 55 | 0.060 |
Why?
|
| Spermatocytes | 1 | 2005 | 12 | 0.060 |
Why?
|
| Cricetulus | 1 | 2005 | 100 | 0.060 |
Why?
|
| Epididymis | 1 | 2005 | 26 | 0.060 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 176 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 49 | 0.060 |
Why?
|
| Isomerism | 1 | 2004 | 28 | 0.060 |
Why?
|
| Gonads | 1 | 2004 | 15 | 0.060 |
Why?
|
| Iodine | 1 | 2004 | 19 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 2004 | 24 | 0.060 |
Why?
|
| Biological Transport | 1 | 2005 | 293 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2004 | 31 | 0.060 |
Why?
|
| Calibration | 1 | 2004 | 67 | 0.060 |
Why?
|
| Endocrinology | 1 | 2004 | 21 | 0.060 |
Why?
|
| Chorionic Gonadotropin | 2 | 1996 | 15 | 0.060 |
Why?
|
| Epitopes | 4 | 2000 | 295 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2005 | 864 | 0.060 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2003 | 33 | 0.050 |
Why?
|
| Leptin | 1 | 2003 | 85 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2004 | 229 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 317 | 0.050 |
Why?
|
| Luteal Phase | 2 | 1994 | 28 | 0.050 |
Why?
|
| Endocrine System | 1 | 2002 | 17 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 2002 | 21 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1194 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 2002 | 55 | 0.050 |
Why?
|
| Smad8 Protein | 2 | 2016 | 3 | 0.050 |
Why?
|
| Smad5 Protein | 2 | 2016 | 7 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 1995 | 411 | 0.050 |
Why?
|
| Hypertension | 1 | 2007 | 590 | 0.050 |
Why?
|
| Stimulation, Chemical | 1 | 2001 | 18 | 0.040 |
Why?
|
| Epithelium | 2 | 1998 | 95 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2000 | 3258 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 283 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 1998 | 1139 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 337 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 2000 | 29 | 0.040 |
Why?
|
| Alleles | 1 | 2000 | 445 | 0.040 |
Why?
|
| Biological Assay | 5 | 2004 | 58 | 0.040 |
Why?
|
| Feedback | 2 | 1995 | 89 | 0.040 |
Why?
|
| Postmenopause | 2 | 1997 | 237 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 189 | 0.040 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 1997 | 9 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2018 | 174 | 0.040 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 1997 | 13 | 0.040 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1997 | 31 | 0.040 |
Why?
|
| Base Sequence | 2 | 2000 | 1333 | 0.030 |
Why?
|
| Protein Conformation | 3 | 2008 | 774 | 0.030 |
Why?
|
| Androgens | 1 | 1996 | 48 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2007 | 48 | 0.030 |
Why?
|
| Zygote | 1 | 1996 | 44 | 0.030 |
Why?
|
| Peptides | 1 | 2000 | 574 | 0.030 |
Why?
|
| Corpus Luteum | 2 | 1996 | 8 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1992 | 231 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 42 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1996 | 77 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2016 | 34 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 89 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1996 | 29 | 0.030 |
Why?
|
| Apoptosis | 2 | 2002 | 1066 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1996 | 36 | 0.030 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 23 | 0.030 |
Why?
|
| Estrogens | 1 | 1996 | 115 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 1996 | 40 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2005 | 705 | 0.030 |
Why?
|
| Culture Media | 2 | 1996 | 79 | 0.030 |
Why?
|
| Adolescent | 2 | 2005 | 6172 | 0.030 |
Why?
|
| Anthraquinones | 1 | 2015 | 4 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2015 | 30 | 0.030 |
Why?
|
| Endocrine Glands | 1 | 1995 | 6 | 0.030 |
Why?
|
| Sertoli Cells | 2 | 2013 | 13 | 0.030 |
Why?
|
| Amino Acids | 2 | 1994 | 146 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2005 | 15 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 25 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2015 | 25 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2016 | 118 | 0.030 |
Why?
|
| Smad Proteins | 2 | 2005 | 22 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 112 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 43 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 1998 | 502 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 375 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 303 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2005 | 256 | 0.030 |
Why?
|
| Exercise Test | 1 | 2015 | 250 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 399 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 27 | 0.030 |
Why?
|
| Walking | 1 | 2015 | 238 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2013 | 67 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2008 | 1143 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 202 | 0.020 |
Why?
|
| Horse Diseases | 1 | 1991 | 20 | 0.020 |
Why?
|
| Horses | 1 | 1991 | 52 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 515 | 0.020 |
Why?
|
| Menstruation | 1 | 1991 | 34 | 0.020 |
Why?
|
| Infertility | 1 | 1991 | 31 | 0.020 |
Why?
|
| Chromatography, Affinity | 2 | 2004 | 48 | 0.020 |
Why?
|
| Kidney | 2 | 2010 | 444 | 0.020 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2010 | 15 | 0.020 |
Why?
|
| Adenylate Kinase | 1 | 2010 | 18 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1990 | 25 | 0.020 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2010 | 9 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2010 | 21 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 125 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 2010 | 9 | 0.020 |
Why?
|
| Genitalia, Female | 1 | 2010 | 18 | 0.020 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2009 | 2 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2010 | 18 | 0.020 |
Why?
|
| Urothelium | 1 | 2010 | 22 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 121 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2010 | 41 | 0.020 |
Why?
|
| Antibodies | 1 | 1990 | 182 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1990 | 98 | 0.020 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 1988 | 2 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 1184 | 0.020 |
Why?
|
| Electrons | 1 | 2008 | 36 | 0.020 |
Why?
|
| Phenotype | 2 | 2004 | 1193 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 52 | 0.020 |
Why?
|
| Follicle Stimulating Hormone, beta Subunit | 1 | 1988 | 6 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 278 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1997 | 5403 | 0.020 |
Why?
|
| Biomarkers | 1 | 1992 | 1385 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 1986 | 70 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 134 | 0.020 |
Why?
|
| Hemochromatosis Protein | 1 | 2006 | 4 | 0.020 |
Why?
|
| Drug Stability | 1 | 1986 | 143 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 1985 | 14 | 0.020 |
Why?
|
| Animals, Wild | 1 | 1985 | 13 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 733 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 1724 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2005 | 68 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2005 | 35 | 0.010 |
Why?
|
| Leuprolide | 2 | 1996 | 16 | 0.010 |
Why?
|
| Nervous System | 1 | 2005 | 69 | 0.010 |
Why?
|
| Body Patterning | 1 | 2005 | 81 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2005 | 112 | 0.010 |
Why?
|
| Lysine | 1 | 2004 | 82 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 175 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 151 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2005 | 204 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 2003 | 13 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 219 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 166 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 2540 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1284 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 383 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2174 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 247 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 165 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 34 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 47 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 103 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2002 | 166 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2002 | 318 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 16 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 2000 | 11 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 324 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 2000 | 48 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 378 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 5303 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2002 | 520 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2000 | 392 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 1180 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1998 | 40 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 671 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1996 | 35 | 0.010 |
Why?
|
| Cell Separation | 1 | 1996 | 147 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1996 | 97 | 0.010 |
Why?
|
| Immunoradiometric Assay | 1 | 1996 | 3 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1996 | 35 | 0.010 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1996 | 30 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1996 | 51 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1995 | 11 | 0.010 |
Why?
|
| Sheep | 1 | 1995 | 179 | 0.010 |
Why?
|
| Embryo Transfer | 1 | 1992 | 24 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1992 | 80 | 0.010 |
Why?
|
| Leydig Cells | 1 | 1991 | 12 | 0.010 |
Why?
|
| Ethanolamines | 1 | 1989 | 18 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1989 | 16 | 0.010 |
Why?
|
| Seminal Plasma Proteins | 1 | 1989 | 7 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1989 | 40 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 1987 | 13 | 0.000 |
Why?
|
| Filtration | 1 | 1987 | 20 | 0.000 |
Why?
|
| Menopause | 1 | 1988 | 257 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1991 | 1937 | 0.000 |
Why?
|
| Child | 1 | 1991 | 4444 | 0.000 |
Why?
|